National Health Investors Inc filed 2 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-07-27. Between them they name 3 people, with 2 appointments and 1 departure. Each change below is quoted from the filing and linked to it.
Every change, newest first
Appointed: Christian Maingot, Chief Operations Officer, effective 2026-07-27
On July 22, 2026, the Board of Directors of National Health Investors, Inc. (the "Company") appointed Christian Maingot, 56, as Chief Operations Officer of the Company, effective July 27, 2026.
Departing: John L. Spaid, Chief Financial Officer, effective 2026-07-01
CFO Transition On April 21, 2026, John L. Spaid notified the Board of Directors (the "Board") of National Health Investors, Inc. (the "Company") of his intention to retire from his position as Executive Vice President of Finance, Chief Financial Officer and Treasurer, effective as of July 1, 2026.
Appointed: Todd Siefert, Executive Vice President Corporate Finance, effective 2026-06-01
On April 20, 2026, Todd Siefert, 52, was appointed as Executive Vice President Corporate Finance, effective June 1, 2026.
Find people with the same kind of experience as the Chief Operations Officer at National Health Investors Inc, with the record behind each one.
Find candidates like Chief Operations Officer at National Health Investors IncNew leaders review vendors and budgets in their first months. Get an alert the next time National Health Investors Inc is in the news or changes leadership.
Get an alert when National Health Investors Inc changes leadershipTools for this story
Each opens in a new tab, filled in for National Health Investors Inc. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.